<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Cochran Bigum | Activity</title>
	<link>https://brycefoster.com/members/yogurtberry70/activity/</link>
	<atom:link href="https://brycefoster.com/members/yogurtberry70/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Cochran Bigum.</description>
	<lastBuildDate>Sat, 17 Oct 2026 15:00:38 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">583224a26eee954c237b65261dc6c808</guid>
				<title>Cochran Bigum posted an update: Navigating GLP-1 Medications in Germany: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1526436/</link>
				<pubDate>Mon, 06 Apr 2026 22:17:17 +0000</pubDate>

									<content:encoded><![CDATA[<p>Navigating GLP-1 Medications in Germany: A Comprehensive Guide to Brands, Usage, and Regulations</p>
<p>The landscape of metabolic health treatment has gone through a substantial improvement over the last decade, particularly with the introduction of Glucagon-like peptide-1 (GLP-1) receptor agonists. In Germany, these medications have actually become&hellip;<span class="activity-read-more" id="activity-read-more-1526436"><a href="https://brycefoster.com/activity/p/1526436/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b70e67ec2891ad697c81179b1367813a</guid>
				<title>Cochran Bigum became a registered member</title>
				<link>https://brycefoster.com/activity/p/1526386/</link>
				<pubDate>Mon, 06 Apr 2026 21:52:29 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>